Crossmark

Radiomics based on multiphasic contrast-enhanced CT combined with clinical features for differentiating hypovascular pancreatic neuroendocrine tumors and pancreatic ductal adenocarcinoma

Crossref DOI link: https://doi.org/10.1007/s00432-026-06481-1

Published Online: 2026-04-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xia, Fan https://orcid.org/0009-0003-5761-3406
Yu, Jie https://orcid.org/0009-0006-3333-9379
Wang, Jianhua https://orcid.org/0000-0001-5874-2080
Wang, Zhongqiu https://orcid.org/0000-0002-3669-4302
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82371919)

Jiangsu Provincial Key Research and Development Program (BE2023789)
License Information

Text and Data Mining valid from 2026-04-25

Version of Record valid from 2026-04-25
More Information

Article History

Received: 15 March 2026

Accepted: 4 April 2026

First Online: 25 April 2026

Declarations

:

: The authors declare no competing interests.

: This retrospective study was approved by the Institutional Review Board of the Affiliated Hospital of Nanjing University of Chinese Medicine (Approval No. 2022NL-060–02) and was performed in accordance with the principles of the Declaration of Helsinki.

: The requirement for written informed consent was waived by the Institutional Review Board because of the retrospective nature of the study.

: Not applicable.

Document is current

Any future updates will be listed below